RECALL OF FUROSEMIDE TABLETS 40MG BP MANUFACTURED BY KAUSIKH THERAPEUTICS LTD INDIA
Publisher
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Zambia Medicines Regulatory Authority (ZAMRA)
- Region
- Global
- Scope
- Regulatory
- Published
- October 9, 2025
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on zamra.co.zm
Leave the platform to read the original full article on the publisher site.
Source: Zambia Medicines Regulatory Authority (ZAMRA)
Scope: Regulatory
Related coverage
More related coverage
Drug label update: Acetaminophen Extra Strength
Official structured record identifier: 9d34abc2-3a9a-b68f-80d4-4ede1eb1e45f.
Drug label update: Allergy Relief
Official structured record identifier: 44da36d2-1881-e779-d3a2-13ea828f9240.
New map shows how pharmaceuticals support jobs, health and growth across every UK nation
Unpaid carers action plan: recognise, refer, reach
This action plan aims to improve the lives of unpaid carers in England.